|
End-of-day quote
Taiwan S.E.
2026-10-29
|
5-day change | 1st Jan Change | ||
| 16.45 TWD | +0.61% |
|
-4.91% | -0.30% |
Company Valuation: Diamond Biofund Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Market Cap 1 | 48,069 | 41,446 | 27,810 | 14,058 |
| Change | - | -13.78% | -32.9% | -49.45% |
| Enterprise Value (EV) 1 | 37,335 | 31,928 | 22,798 | 10,260 |
| Change | - | -14.48% | -28.59% | -55% |
| P/E | 62x | -14.7x | -11x | -12x |
| PBR | 4.35x | 3.22x | 2.68x | 1.53x |
| PEG | -0.9x | 0x | 1x | 0.2x |
| Capitalization / Revenue | 47.3x | -17x | -12.5x | -13.1x |
| EV / Revenue | 36.8x | -13.1x | -10.2x | -9.56x |
| EV / EBITDA | 41.3x | -12.3x | -9.53x | -8.45x |
| EV / EBIT | 41.4x | -12.3x | -9.5x | -8.4x |
| EV / FCF | 69.9x | -18.8x | -17x | -11.7x |
| FCF Yield | 1.43% | -5.33% | -5.9% | -8.54% |
| Dividend per Share 2 | 0.1695 | - | - | - |
| Rate of return | 0.26% | - | - | - |
| EPS 2 | 1.034 | -3.32 | -2.961 | -1.38 |
| Distribution rate | 16.4% | - | - | - |
| Net sales 1 | 1,016 | -2,440 | -2,229 | -1,073 |
| EBITDA 1 | 903.6 | -2,597 | -2,393 | -1,214 |
| EBIT 1 | 902.2 | -2,598 | -2,399 | -1,221 |
| Net income 1 | 797.8 | -2,583 | -2,518 | -1,175 |
| Net Debt 1 | -10,734 | -9,518 | -5,012 | -3,797 |
| Reference price 2 | 64.15 | 48.80 | 32.70 | 16.50 |
| Nbr of stocks (in thousands) | 749,300 | 849,300 | 850,470 | 851,970 |
| Announcement Date | 3/24/23 | 2/29/24 | 2/26/25 | 3/12/26 |
1TWD in Million2TWD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 430M | ||
| 21.99x | 6x | 12.96x | 1.98% | 179B | ||
| 13.55x | 3.28x | - | 2.68% | 142B | ||
| 15.92x | 7.28x | - | 1.55% | 99.99B | ||
| 19.48x | 7.01x | 12.49x | 4.34% | 93.62B | ||
| 14.68x | 9.92x | 16.99x | 0.84% | 83.52B | ||
| 22.3x | 11.64x | 19.16x | 4.25% | 75.45B | ||
| 18.32x | 10.54x | 8.12x | 1.97% | 67B | ||
| 12.91x | 4.89x | - | 2.02% | 47.35B | ||
| Average | 17.39x | 7.57x | 13.94x | 2.45% | 87.65B | |
| Weighted average by Cap. | 17.80x | 7.06x | 13.83x | 2.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 6901 Stock
- Valuation Diamond Biofund Inc.
Select your edition
All financial news and data tailored to specific country editions
















